Enantone 1-Month DPS 3.75 mg/Enantone 3-Month DPS 11.25 mg/Enantone 6-Month DPS 30 mg安怡泰

Enantone 1-Month DPS 3.75 mg/Enantone 3-Month DPS 11.25 mg/Enantone 6-Month DPS 30 mg Drug Interactions

leuprorelin

Manufacturer:

Distributor:

Firma Chun Cheong

Concise Prescribing Info Full Prescribing Info Contents Description Action Indications/Uses Dosage/Direction for Use Overdosage Contraindications Special Precautions Use In Pregnancy & Lactation Adverse Reactions Drug Interactions Caution For Usage Storage MIMS Class ATC Classification Regulatory Classification Presentation/Packing

Full Prescribing Info

Drug Interactions

Enantone 1-Month DPS 3.75 mg: Endometriosis, Uterine myoma: Precautions for coadministration: ENANTONE should be administered with care when coadministered with the following drugs. (See Table 18.)

Click on icon to see table/diagram/image

Enantone 3-Month DPS 11.25 mg: Since androgenic deprivation treatment may prolong the QT interval, the concomitant use of Enantone with medicinal products known to prolong the QT interval or associated with Torsades de Pointes, such as class IA antiarrhythmic medicinal products (e.g. quinidine, disopyramide) or class III ones (e.g. amiodarone, sotalol, dofetilide, ibutilide), methadone, moxifloxacin and antipsychotics should be carefully investigated (see Precautions).
Enantone 6-Month DPS 30 mg: No drug interactions have been reported.

Enantone 1-Month DPS 3.75 mg/Enantone 3-Month DPS 11.25 mg/Enantone 6-Month DPS 30 mg Drug Interactions

leuprorelin

Manufacturer:

Takeda

Distributor:

Zuellig

Firma Chun Cheong